Plant cells push away microtubules to control cell division, study finds

Reviewers’ Notes Every time a stem cell divides, one daughter cell remains a stem cell while the other takes off on its own developmental journey. But both daughter cells require specific and different cellular materials to fulfill their destinies. Animal stem cells use the cytoskeleton – a transient network of structural tubules – to physically pull the correct materials from […]

Continue reading »

New data on COVID-19 vaccine response and clinical outcomes in patients with impaired immune systems

Researchers and clinicians from the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust are part of the ongoing OCTAVE (Observational Cohort Trial-T-cells Antibodies and Vaccine Efficacy in SARS-CoV-2) trial, which is led by the Universities of Glasgow, Birmingham and Oxford and a consortium of leading UK institutions. Updated data from the OCTAVE study show, for the first time, […]

Continue reading »

Immunotherapy significantly improves overall survival for advanced NSCLC patients

Reviewers’ Notes A global study, led by UCL and UCLH and sponsored by Roche, has shown that the cancer immunotherapy atezolizumab significantly improved the overall survival of advanced stage non-small cell lung cancer patients who were not able to be treated with platinum-containing chemotherapy, when compared to single-agent chemotherapy. The trial results, published today in The Lancet, are good news […]

Continue reading »

Eliminating extra chromosomes in cancer cells prevents tumor growth, new study reveals

Cancer cells with extra chromosomes depend on those chromosomes for tumor growth, a new Yale study reveals, and eliminating them prevents the cells from forming tumors. The findings, said the researchers, suggest that selectively targeting extra chromosomes may offer a new route for treating cancer. The study was published July 6 in the journal Science. Human cells typically have 23 […]

Continue reading »

Novavax COVID-19 vaccine as a second dose generates high immune response in young people, finds study

Reactions were mostly mild-to-moderate, with fewest reactions in the fractional Pfizer-BioNTech group Participants in the fractional Pfizer-BioNTech group were more likely to have a breakthrough infection than the standard Pfizer-BioNTech and Novavax groups Antibody responses were similar for all three groups at 236 days after second doses were administered Source: Read Full Article

Continue reading »

Lesser known Alzheimers symptom that can happen while driving

Alzheimer’s disease has affected numerous families throughout the UK, and it has recently made headlines after Fiona Phillips revealed her diagnosis of early-onset Alzheimer’s. As one of the most common forms of dementia, early diagnosis is crucial for accessing appropriate support options. While some signs of Alzheimer’s are expected, others may come as a surprise. Alzheimer’s is a brain disease […]

Continue reading »
1 102 103 104 105 106 1,322